دورية أكاديمية
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group
| العنوان: | Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group |
|---|---|
| المؤلفون: | Koschmieder, SteffenAff1, Aff2, IDs00277022050807_cor1, Isfort, SusanneAff1, Aff2, Wolf, DominikAff2, Aff3, Aff4, Heidel, Florian H.Aff5, Aff6, Hochhaus, Andreas, Schafhausen, Philippe, Griesshammer, Martin, Wolleschak, Denise, Platzbecker, UweAff10, Aff11, Döhner, Konstanze, Jost, Philipp J.Aff13, Aff14, Parmentier, StefaniAff15, Aff16, Schaich, Markus, von Bubnoff, NikolasAff17, Aff18, Stegelmann, Frank, Maurer, AngelaAff1, Aff2, Crysandt, MartinaAff1, Aff2, Gezer, DenizAff1, Aff2, Kortmann, MaikeAff2, Aff19, Franklin, JeremyAff2, Aff20, Frank, JuliaAff2, Aff20, Hellmich, MartinAff2, Aff20, Brümmendorf, Tim H.Aff1, Aff2 |
| المصدر: | Annals of Hematology. 102(2):349-358 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 09395555 14320584 |
|---|---|
| DOI: | 10.1007/s00277-022-05080-7 |